• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁和精神分裂症中的快感缺失:一种跨诊断的挑战。

Anhedonia in depression and schizophrenia: A transdiagnostic challenge.

机构信息

Arthur Sommer Rotenberg Suicide and Depression Studies Program, St. Michael's Hospital, Toronto, ON, Canada.

Royal College of Surgeons in Ireland, School of Medicine, Dublin, Ireland.

出版信息

CNS Neurosci Ther. 2018 Jul;24(7):615-623. doi: 10.1111/cns.12854. Epub 2018 Apr 23.

DOI:10.1111/cns.12854
PMID:29687627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6489811/
Abstract

BACKGROUND

Anhedonia, as a dysregulation of the reward circuit, is present in both Major Depressive Disorder (MDD) and schizophrenia (SZ).

AIMS

To elucidate the clinical and neurobiological differences between schizophrenia (SZ) and depression (MDD) in regard to anhedonia, while reconciling the challenges and benefits of assessing anhedonia as a transdiagnostic feature under the Research Domain Criteria (RDoC) framework.

METHODS

In this review, we summarize data from publications examining anhedonia or its underlying reward deficits in SZ and MDD. A literature search was conducted in OVID Medline, PsycINFO and EMBASE databases between 2000 and 2017.

RESULTS

While certain subgroups share commonalities, there are also important differences. SZ may be characterized by a disorganization, rather than a deficiency, in reward processing and cognitive function, including inappropriate energy expenditure and focus on irrelevant cues. In contrast, MDD has been characterized by deficits in anticipatory pleasure, development of reward associations, and integration of information from past experience. Understanding the roles of neurotransmitters and aberrant brain circuitry is necessary to appreciate differences in reward function in SZ and MDD.

CONCLUSION

Anhedonia as a clinical presentation of reward circuit dysregulation is an important and relatively undertreated symptom of both SZ and MDD. In order to improve patient outcomes and quality of life, it is important to consider how anhedonia fits into both diagnoses.

摘要

背景

快感缺失作为奖赏回路的失调,存在于重性抑郁障碍(MDD)和精神分裂症(SZ)中。

目的

阐明精神分裂症(SZ)和抑郁症(MDD)在快感缺失方面的临床和神经生物学差异,同时协调在研究领域标准(RDoC)框架下将快感缺失评估为跨诊断特征的挑战和益处。

方法

在这篇综述中,我们总结了在 SZ 和 MDD 中检查快感缺失或其潜在奖赏缺陷的出版物中的数据。在 2000 年至 2017 年期间,在 OVID Medline、PsycINFO 和 EMBASE 数据库中进行了文献检索。

结果

虽然某些亚组具有共同之处,但也存在重要差异。SZ 可能表现为奖赏处理和认知功能的紊乱,而不是缺陷,包括不适当的能量消耗和对不相关线索的关注。相比之下,MDD 的特点是预期快感、奖赏关联的发展以及对过去经验信息的整合存在缺陷。理解神经递质和异常大脑回路的作用对于理解 SZ 和 MDD 中奖赏功能的差异是必要的。

结论

快感缺失作为奖赏回路失调的临床表现,是 SZ 和 MDD 中一种重要且相对治疗不足的症状。为了改善患者的预后和生活质量,重要的是要考虑快感缺失如何适用于两种诊断。

相似文献

1
Anhedonia in depression and schizophrenia: A transdiagnostic challenge.抑郁和精神分裂症中的快感缺失:一种跨诊断的挑战。
CNS Neurosci Ther. 2018 Jul;24(7):615-623. doi: 10.1111/cns.12854. Epub 2018 Apr 23.
2
Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis.以跨诊断方法映射快感缺乏特异性功能障碍:一项激活可能性估计元分析。
Brain Imaging Behav. 2016 Sep;10(3):920-39. doi: 10.1007/s11682-015-9457-6.
3
Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits.抑郁症和精神分裂症中的快感缺失:大脑奖赏与厌恶回路
Neuropsychiatr Dis Treat. 2022 Jul 7;18:1385-1396. doi: 10.2147/NDT.S367839. eCollection 2022.
4
Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?多巴胺失调假说:重性抑郁障碍和精神分裂症中动机性快感缺失的共同基础?
Rev Neurosci. 2018 Sep 25;29(7):727-744. doi: 10.1515/revneuro-2017-0091.
5
Mechanisms Underlying Motivational Deficits in Psychopathology: Similarities and Differences in Depression and Schizophrenia.精神病理学中动机缺陷的潜在机制:抑郁症和精神分裂症的异同
Curr Top Behav Neurosci. 2016;27:411-49. doi: 10.1007/7854_2015_376.
6
Electroconvulsive therapy effects on anhedonia and reward circuitry anatomy: A dimensional structural neuroimaging approach.电抽搐疗法对快感缺失和奖赏回路解剖结构的影响:一种维度结构神经影像学方法。
J Affect Disord. 2022 Sep 15;313:243-250. doi: 10.1016/j.jad.2022.06.062. Epub 2022 Jun 25.
7
Reward processing and mood-related symptoms: An RDoC and translational neuroscience perspective.奖赏处理与情绪相关症状:基于研究领域标准(RDoC)和转化神经科学的视角
J Affect Disord. 2017 Jul;216:3-16. doi: 10.1016/j.jad.2017.02.001. Epub 2017 Feb 4.
8
Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol.优化行为范式以促进精神分裂症和重度抑郁症中快感缺乏及奖赏处理缺陷新疗法的开发:研究方案
Front Psychiatry. 2020 Nov 5;11:536112. doi: 10.3389/fpsyt.2020.536112. eCollection 2020.
9
Range adaptive value representations in schizophrenia and major depression.精神分裂症和重度抑郁症中的范围适应性价值表征
Asian J Psychiatr. 2024 Feb;92:103880. doi: 10.1016/j.ajp.2023.103880. Epub 2023 Dec 21.
10
A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.精神分裂症和抑郁症阴性症状病理生理学的跨疾病诊断方法
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109862. doi: 10.1016/j.pnpbp.2020.109862. Epub 2020 Jan 10.

引用本文的文献

1
Happy or not? An investigative study on well-being and anhedonia in everyday life.快乐与否?一项关于日常生活中的幸福感与快感缺失的调查研究。
PLoS One. 2025 Sep 11;20(9):e0331769. doi: 10.1371/journal.pone.0331769. eCollection 2025.
2
Childhood Neglect rather than Abuse Is More Strongly Associated with Anhedonia across Major Depression and Obsessive-Compulsive Disorder Patients and University Students.童年期忽视而非虐待与重度抑郁症、强迫症患者及大学生的快感缺失关联更强。
Depress Anxiety. 2023 Oct 20;2023:2429889. doi: 10.1155/2023/2429889. eCollection 2023.
3
MeCP2 Modulates Depression-Like Behaviors Comorbid to Chronic Pain by Regulating Adult Hippocampal Neurogenesis.MeCP2通过调节成年海马神经发生来调控与慢性疼痛共病的抑郁样行为。
CNS Neurosci Ther. 2025 Mar;31(3):e70311. doi: 10.1111/cns.70311.
4
GPR139, an Ancient Receptor and an Emerging Target for Neuropsychiatric and Behavioral Disorders.GPR139,一种古老的受体,也是神经精神和行为障碍的新兴靶点。
Mol Neurobiol. 2025 Mar 18. doi: 10.1007/s12035-025-04828-2.
5
Anhedonia relates to reduced striatal reward anticipation in depression but not in schizophrenia or bipolar disorder: A transdiagnostic study.快感缺乏与抑郁症中纹状体奖赏预期降低有关,但与精神分裂症或双相情感障碍无关:一项跨诊断研究。
Cogn Affect Behav Neurosci. 2025 Apr;25(2):501-514. doi: 10.3758/s13415-024-01261-1. Epub 2025 Jan 30.
6
The interaction network and potential clinical effectiveness of dimensional psychopathology phenotyping based on EMR: a Bayesian network approach.基于电子病历的维度精神病理学表型的交互网络及潜在临床疗效:一种贝叶斯网络方法
BMC Psychiatry. 2025 Jan 28;25(1):81. doi: 10.1186/s12888-025-06510-2.
7
A transdiagnostic approach of negative symptoms in psychiatric disorders: replication of a two-factor structure in major depressive disorder and bipolar disorder.精神障碍中阴性症状的跨诊断方法:重度抑郁症和双相情感障碍中双因素结构的复制
Eur Arch Psychiatry Clin Neurosci. 2024 Nov 2. doi: 10.1007/s00406-024-01934-5.
8
Using Network Analysis to Subgroup Risk Factors for Depressive Symptoms in College Students.运用网络分析对大学生抑郁症状的风险因素进行亚组分析。
Psychol Res Behav Manag. 2024 Oct 21;17:3625-3636. doi: 10.2147/PRBM.S479975. eCollection 2024.
9
The antipsychotic potential of on ketamine-induced rats.氯胺酮诱导大鼠的抗精神病潜力。 需注意,你提供的原文似乎不完整,“on ketamine-induced rats”前面应该还有相关药物或物质等内容。
IBRO Neurosci Rep. 2024 Jun 14;17:96-107. doi: 10.1016/j.ibneur.2024.06.003. eCollection 2024 Dec.
10
Depression, an unmet health need in Africa: Understanding the promise of ketamine.抑郁症,非洲未被满足的健康需求:了解氯胺酮的前景。
Heliyon. 2024 Mar 28;10(7):e28610. doi: 10.1016/j.heliyon.2024.e28610. eCollection 2024 Apr 15.

本文引用的文献

1
Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.探究精神分裂症患者和健康对照组在动机缺陷下的消费性和预期性愉悦。
Psychiatry Res. 2017 Aug;254:112-117. doi: 10.1016/j.psychres.2017.04.040. Epub 2017 Apr 23.
2
Neural mechanisms of reinforcement learning in unmedicated patients with major depressive disorder.未服药的重性抑郁障碍患者强化学习的神经机制。
Brain. 2017 Apr 1;140(4):1147-1157. doi: 10.1093/brain/awx025.
3
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.卡利拉嗪与利培酮单药治疗精神分裂症以阴性症状为主的患者:一项随机、双盲、对照试验。
Lancet. 2017 Mar 18;389(10074):1103-1113. doi: 10.1016/S0140-6736(17)30060-0. Epub 2017 Feb 7.
4
Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study.情绪和精神障碍中常见的维度性奖赏缺陷:一项全脑连接组关联研究。
Am J Psychiatry. 2017 Jul 1;174(7):657-666. doi: 10.1176/appi.ajp.2016.16070774. Epub 2017 Jan 31.
5
The current conceptualization of negative symptoms in schizophrenia.精神分裂症阴性症状的当前概念化。
World Psychiatry. 2017 Feb;16(1):14-24. doi: 10.1002/wps.20385.
6
Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study.阿戈美拉汀治疗抑郁症患者快感缺失的有效性:一项门诊、开放标签的真实世界研究。
Hum Psychopharmacol. 2016 Nov;31(6):412-418. doi: 10.1002/hup.2557.
7
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.加拿大情绪与焦虑治疗网络(CANMAT)2016年成人重度抑郁症管理临床指南:第3节. 药物治疗。
Can J Psychiatry. 2016 Sep;61(9):540-60. doi: 10.1177/0706743716659417. Epub 2016 Aug 2.
8
Assessing anhedonia in depression: Potentials and pitfalls.评估抑郁症中的快感缺失:潜力与陷阱。
Neurosci Biobehav Rev. 2016 Jun;65:21-35. doi: 10.1016/j.neubiorev.2016.03.004. Epub 2016 Mar 6.
9
Diminished effort on a progressive ratio task in both unipolar and bipolar depression.单相抑郁和双相抑郁在渐进比率任务中努力程度降低。
J Affect Disord. 2016 May 15;196:97-100. doi: 10.1016/j.jad.2016.02.003. Epub 2016 Feb 16.
10
Individual Variations in Nucleus Accumbens Responses Associated with Major Depressive Disorder Symptoms.与重度抑郁症症状相关的伏隔核反应的个体差异。
Sci Rep. 2016 Feb 16;6:21227. doi: 10.1038/srep21227.